Inspire Medical Systems Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Inspire Medical Systems Inc 's inventory turnover ratio sequentially decreased to 0.9 in the first quarter 2026, unsurprisingly, as the Inspire Medical Systems Inc markets continue to deteriorate, and INSP's faces growing challenges to bring down its inventories. Inspire Medical Systems Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 406 days, from 348 days, in the Dec 31 2025 quarter.

Within Healthcare sector 325 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 479 in the fourth quarter 2025, to 1474.

INSP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Inspire Medical Systems Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INSP Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	66.69 %	81.35 %	110.25 %	106.07 %	103.63 %
Y / Y Cost of Sales Growth	-10 %	2.7 %	-3.13 %	17.24 %	25 %
Inventory Turnover Ratio (TTM)	0.9	1.05	1.19	1.44	1.67
INSP's Total Ranking	# 1474	# 479	# 1035	# 719	# 1450
Average inventory processing period	404	349	306	253	218
Seq. Inventory Growth	14.41 %	2.48 %	16.56 %	21.97 %	24.48 %
Seq. Cost of Sales Growth	-28.95 %	22.58 %	-8.82 %	13.33 %	-18.92 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 148
Healthcare Sector	# 326
Overall Market	# 1474

Inventory Turnover Ratio Statistics
High	Average	Low
5.42	2.63	0.9
(Jun 30 2023)		(Mar 31 2026)

INSP Company Profile >> Back to INSP Efficiency Comparisons >> Compare INSP Inventory Turnover Ratio to its Competitors

Financial Statements
Inspire Medical Systems Inc 's Inventories	$ 166 Millions	Visit INSP's Balance sheet
Inspire Medical Systems Inc 's Cost of Revenues TTM	$ 130 Millions	Visit INSP's Income Statement
What are INSP's Sales?		Visit INSP's Sales by Segment

Other Inventory Turnover Ratios
Inspire Medical Systems Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
INSP's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for INSP's Competitors
Inventory Turnover Ratio for INSP's Suppliers
Inventory Turnover Ratio for INSP's Customers

You may also want to know
INSP's Sales Growth Rates	INSP's Pe Price to earnings ratio	INSP's Receivables Turnover Ratio	INSP's Stock Quote
INSP's Net Income Growth Rates	INSP's Ps Price to Sales ratio	INSP's Sales per Employee	INSP's Asset Turnover Ratio
INSP's Net Margin	INSP's Pb Price to Book ratio	INSP's Financial Strength Ratios	INSP's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Boston Scientific Corporation	2.15	$ 6,358.000 Millions	$ 2,961 Millions
Ultragenyx Pharmaceutical Inc	2.15	$ 110.338 Millions	$ 51 Millions
Yunhong Green Cti Ltd	2.14	$ 18.000 Millions	$ 8 Millions
Inspiremd Inc	2.14	$ 7.000 Millions	$ 3 Millions
Phibro Animal Health Corporation	2.13	$ 1,010.688 Millions	$ 475 Millions
Accuray Incorporated	2.11	$ 313.685 Millions	$ 149 Millions
Amphastar Pharmaceuticals Inc	2.09	$ 379.402 Millions	$ 181 Millions
Axsome Therapeutics Inc	2.06	$ 52.414 Millions	$ 25 Millions
Clearpoint Neuro Inc	2.05	$ 15.298 Millions	$ 7 Millions
Journey Medical Corp	2.05	$ 22.352 Millions	$ 11 Millions
Fortress Biotech Inc	2.05	$ 22.352 Millions	$ 11 Millions
Lifevantage Corp	2.04	$ 41.000 Millions	$ 20 Millions
Bausch and Lomb Corp	2.04	$ 2,046.000 Millions	$ 1,002 Millions
Organon and Co	2.03	$ 2,908.000 Millions	$ 1,430 Millions
Innoviva Inc	2.03	$ 84.000 Millions	$ 41 Millions
Elutia Inc	2.03	$ 6.357 Millions	$ 3 Millions
Orasure Technologies Inc	2.03	$ 64.878 Millions	$ 32 Millions
Aytu Biopharma Inc	2.02	$ 19.000 Millions	$ 9 Millions
Bioventus Inc	2.02	$ 180.570 Millions	$ 90 Millions
Sanara Medtech Inc	2.00	$ 7.000 Millions	$ 3 Millions
Dariohealth Corp	2.00	$ 9.000 Millions	$ 4 Millions
Retractable Technologies Inc	1.99	$ 36.969 Millions	$ 19 Millions
Intuitive Surgical Inc	1.97	$ 3,567.000 Millions	$ 1,809 Millions
Cytek Biosciences Inc	1.97	$ 98.182 Millions	$ 50 Millions
Nature s Sunshine Products inc	1.96	$ 133.000 Millions	$ 68 Millions
Skinhealth Systems Inc	1.95	$ 103.000 Millions	$ 53 Millions
Astrotech Corp	1.94	$ 0.671 Millions	$ 0 Millions
Avita Medical Inc	1.94	$ 13.484 Millions	$ 7 Millions
Pacific Biosciences Of California Inc	1.93	$ 100.000 Millions	$ 52 Millions
Scientific Industries Inc	1.92	$ 4.519 Millions	$ 2 Millions

Date modified: 2026-08-30T14:58:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.